Gaby Lisbeth Llamo Hoyos

Gaby Lisbeth Llamo Hoyos

Auto-generated profile, based on publicly available information

Gaby Lisbeth Llamo Hoyos


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 March 2021 in Revista de la Facultad de Medicina Humana
Verified
Journal Article
Open access
PDF file
ECEduardo Rubén Lam Cabanillas
Eduardo Rubén Lam Cabanillas
ARAnthony Omar León Risco
Anthony Omar León Risco
KRKevyn Bryce León Risco
Kevyn Bryce León Risco
GHGaby Lisbeth Llamo Hoyos
Gaby Lisbeth Llamo Hoyos
RZRosa María López Zavaleta
Rosa María López Zavaleta
JSJuan Jorge Huamán Saavedra
Juan Jorge Huamán Saavedra
COVID-19 is a disease caused by SARS-CoV-2, a virus that represents a serious threat to global health. The objective of the article is to deepen into the structure of the structural and non-structural proteins of SARS-CoV-2 and their role during the infection of its target cells; also to propose molecules from in silico studies that inhibit proteins of the viral cycle for potential pharmacological treatments. The SARS-CoV-2 genome has ORFs that encode sixteen non-structural proteins (Nsp1-16), four structural proteins (Spike, Envelope, Membrane, and Nucleocapsid), and nine accessory proteins; that fulfill various functions in the entry of the virus and its viral cycle. In silico studies of drugs such as disulfiram and viomycin, and molecules found in plants as Azadirachta indica, the tea plant, and Andrographis paniculata have shown inhibitory effects on the SARS-CoV-2 viral cycle.